دورية أكاديمية

Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2‑((4-(Benzo[d]-thiazol-5-ylamino)-6‑(tert-butylsulfonyl)-quinazolin-7-yl)oxy)ethyl Dihydrogen Phosphate, for the Treatment of...

التفاصيل البيبلوغرافية
العنوان: Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2‑((4-(Benzo[d]-thiazol-5-ylamino)-6‑(tert-butylsulfonyl)-quinazolin-7-yl)oxy)ethyl Dihydrogen Phosphate, for the Treatment of...
المؤلفون: Haile, Pamela A., Casillas, Linda N., Votta, Bartholomew J., Wang, Gren Z., Charnley, Adam K., Dong, Xiaoyang, Bury, Michael J., Romano, Joseph J., Mehlmann, John F., King, Bryan W., Erhard, Karl F., Hanning, Charles R., Lipshutz, David B., Desai, Biva M., Capriotti, Carol A., Schaeffer, Michelle C., Berger, Scott B., Mahajan, Mukesh K., Reilly, Michael A., Nagilla, Rakesh
المصدر: Journal of Medicinal Chemistry; 7/25/2019, Vol. 62 Issue 14, p6482-6494, 13p
قاعدة البيانات: Supplemental Index
الوصف
تدمد:00222623
DOI:10.1021/acs.jmedchem.9b00575